Oncologic emergencies and urgencies: A comprehensive review

BE Gould Rothberg, TE Quest… - CA: a cancer journal …, 2022 - Wiley Online Library
Patients with advanced cancer generate 4 million visits annually to emergency departments
(EDs) and other dedicated, high‐acuity oncology urgent care centers. Because of both the …

A comprehensive review on neuroendocrine neoplasms: presentation, pathophysiology and management

Q Sultana, J Kar, A Verma, S Sanghvi, N Kaka… - Journal of Clinical …, 2023 - mdpi.com
Neuroendocrine neoplasms (NENs) are a group of heterogeneous tumors with
neuroendocrine differentiation that can arise from any organ. They account for 2% of all …

[HTML][HTML] Mechanism and recent updates on insulin-related disorders

S Kumar, S Senapati, N Bhattacharya… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Insulin, a small protein with 51 amino acids synthesized by pancreatic β-cells, is crucial to
sustain glucose homeostasis at biochemical and molecular levels. Numerous metabolic …

Emerging therapies for advanced insulinomas and glucagonomas

KI Alexandraki, GA Kaltsas… - Endocrine-Related …, 2023 - erc.bioscientifica.com
Pancreatic neuroendocrine neoplasms (panNENs) are rare relatively malignancies that,
despite their frequently slow-growing pattern, have the ability to metastasize. Metastatic …

Ectopic insulinoma: a systematic review

F Guerrero-Perez, N Vilarrasa, LV Huanuco… - Reviews in Endocrine …, 2023 - Springer
Abstract Knowledge of ectopic insulinomas comes from single cases. We performed a
systematic review through PubMed, Web of Science, Embase, eLibrary and ScienceDirect of …

5-Azacytidine inhibits the activation of senescence program and promotes cytotoxic autophagy during Trdmt1-mediated oxidative stress response in insulinoma β-TC …

K Filip, A Lewińska, J Adamczyk-Grochala… - Cells, 2022 - mdpi.com
5-Azacytidine (5-azaC), a methyltransferase inhibitor and anticancer drug, can promote
several cellular stress responses such as apoptosis, autophagy, and senescence. The …

The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective

L Mariën, O Islam, S Chhajlani, W Lybaert… - … Treatment Options in …, 2023 - Springer
Opinion statement Given the considerable heterogeneity in neuroendocrine neoplasms
(NENs), it appears unlikely that a sole biomarker exists capable of fully capturing all useful …

The role of surgery for pancreatic neuroendocrine tumors

IA Ziogas, R Schmitz, D Moris, CJ Vatsaas - Anticancer Research, 2022 - ar.iiarjournals.org
Pancreatic neuroendocrine tumors (PNETs) arise from endocrine pancreatic cells and
comprise 3-5% of pancreatic cancers. Surgical resection is the only potentially curative …

Genetic disorders and insulinoma/glucagonoma

F Marini, F Giusti, ML Brandi - Endocrine-Related Cancer, 2024 - erc.bioscientifica.com
Insulinoma and glucagonoma are two rare functioning neoplasms of the neuroendocrine
cells of the pancreas, respectively, characterized by an uncontrolled over-secretion of insulin …

Endoscopic ultrasound-guided radiofrequency ablation: An effective and safe alternative for the treatment of benign insulinoma

RM Furnica, P Deprez, D Maiter, B Vandeleene… - Annales d' …, 2020 - Elsevier
Background Insulinomas are usually benign, small-sized, well-encapsulated and often
solitary pancreatic tumors. Currently, enucleation is the treatment of choice for sporadic …